Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $64,510.50 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 86,014 shares of Retractable Technologies stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $0.75 per share, for a total transaction of $64,510.50. Following the completion of the purchase, the chief executive officer now directly owns 15,376,794 shares of the company’s stock, valued at approximately $11,532,595.50. This trade represents a 0.56% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Retractable Technologies Price Performance

RVP opened at $0.72 on Monday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies, Inc. has a 52-week low of $0.56 and a 52-week high of $1.22. The stock has a market capitalization of $21.56 million, a PE ratio of -1.33 and a beta of 1.65. The stock’s 50 day moving average price is $0.72 and its 200-day moving average price is $0.72.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Retractable Technologies in a research note on Wednesday, May 14th. They set a “hold” rating on the stock.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC increased its position in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 at the end of the most recent reporting period. Institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.